Kolon Pharmaceutical (002422.SZ) holding subsidiary Kolon Botech received 603 million yuan related payment from Yilian Biopharmaceutical.

ChiNext Finance APP News, Kelun Pharmaceutical (002422.SZ) announced that recently, its controlling subsidiary Sichuan Kelun Botai Biopharmaceutical Co., Ltd. (referred to as "Kelun Botai") received approximately RMB 603 million in revenue to be shared by Kelun Botai from Suzhou Yilian Biopharmaceutical Co., Ltd. (referred to as "Yilian Biopharmaceutical") for the external authorization of YL201.